Investors
Navigation
  • Home
  • Team
  • Companies
  • News & Ideas
  • Careers
  • Investor Portal
Address
BOLD Capital Partners
BOLD Longevity Growth

225 Santa Monica Blvd, Suite 900
Santa Monica, CA 90401

100 Cambridge Street
Boston, MA 02114
Google Maps
Contacts
Email us
Socials
LinkedIn Twitter
Recent Investments
ProRata.ai
ProRata.ai ProRata.ai
Matrisome Bio
Matrisome Bio Matrisome Bio
Aqtual
Aqtual Aqtual
Discure
Discure Discure
Feno Labs
Feno Labs Feno Labs

Switch Therapeutics

 - 
Switch Therapeutics -  Switch Therapeutics - 
Switch Therapeutics Switch Therapeutics
Switch Therapeutics is developing biomarker-gated, innovative genetic medicines to transform the treatment of central nervous system diseases. Switch’s Conditionally Activated siRNA (CASi), developed at Caltech, Harvard Medical School, and City of Hope, combines the best attributes of antisense oligonucleotides (ASO) and siRNAs. Switch is initially focusing on developing our precision medicines for central nervous system (CNS) diseases with high unmet need.
Visit Company Website
Dee Datta
Dee Datta CEO
Technologies
  • Applied AI,
  • Biotechnology,
  • Computational Biology,
  • Sensors
  • Follow
  • LinkedIn
  • Company News
    View All News
    Switch Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
    Healthcare

    Switch Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

    06.25.24

    Read more

    Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
    Healthcare

    Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference

    02.22.24

    Read more

    Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
    Healthcare

    Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference

    02.22.24

    Read more

    Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer
    Healthcare

    Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer

    01.03.24

    Read more

    View All News & Ideas

    Jobs

    Interested in a job at Switch Therapeutics?
    View Jobs
    Omeat
    Omeat
    Next